Riddhi Siddhi Gluco Biols' Q4 FY 2025-26 Quarterly Results

Result Summary

• Riddhi Siddhi Gluco Biols Ltd reported a 63.1% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 63.0%.
• Its expenses for the quarter were down by 54.4% QoQ and 34.6% YoY.
• The net profit increased 2437.2% QoQ and decreased 806.9% YoY.
• The earnings per share (EPS) of Riddhi Siddhi Gluco Biols Ltd declined at 45.92 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Riddhi Siddhi Gluco Biols Ltd operates primarily in the agro-processing industry, focusing on the production and sale of starch derivatives. The company's main products typically include liquid glucose, maize starch, and dextrose, which are used extensively in industries such as food processing, pharmaceuticals, textiles, and paper. As of the latest update, no recent major developments have been noted for the company. This report will provide an analysis of the company's financial performance for Q4 FY26, based on the provided quarterly data.

Revenue

In Q4 FY26, Riddhi Siddhi Gluco Biols Ltd reported a total income of ₹20.06 crores, which represents a significant decrease of 63.1% from the previous quarter's income of ₹54.37 crores. This figure is also 63.0% lower compared to the total income of ₹54.16 crores reported in Q4 FY25. The substantial decline in revenue highlights a notable change in the company's income stream over the quarters and year. Such a drop in revenue could have implications for the company's operational and financial strategies in subsequent periods.

Profitability

The company reported a loss in terms of profitability for Q4 FY26, with a Profit Before Tax (PBT) of -₹3.58 crores. This marks a stark contrast to the PBT of ₹2.49 crores in Q3 FY26 and ₹18.00 crores in Q4 FY25, showing a decline of 243.8% QoQ and 119.9% YoY. The Profit After Tax (PAT) also reflected a downturn, standing at -₹32.73 crores, a significant deviation from -₹1.29 crores in the previous quarter and ₹4.63 crores a year ago. The Earnings Per Share (EPS) followed a similar trend, declining to -₹45.92 from -₹1.80 in Q3 FY26 and ₹6.49 in Q4 FY25, with a dramatic YoY percentage change of -807.6%. These figures indicate a challenging period for the company's profitability metrics.

Operating Metrics

Operating expenses for Riddhi Siddhi Gluco Biols Ltd in Q4 FY26 amounted to ₹23.64 crores. This represents a decrease of 54.4% from ₹51.88 crores in Q3 FY26, and a 34.6% reduction from ₹36.16 crores in the same quarter the previous year. Despite the reduction in expenses, the company's financial performance still resulted in a loss, as indicated by the negative PBT and PAT values. The tax expense in Q4 FY26 was ₹1.37 crores, down by 34.8% QoQ and 91.1% YoY, reflecting the overall decrease in taxable income. The company's financial activities in this quarter suggest a significant shift in its operational and financial landscape, affecting various key performance indicators.